Literature DB >> 1103743

Topically applied griseofulvin in prevention and treatment of Trichophyton mentagrophytes.

W L Epstein, V P Shah, H E Jones, S Riegelman.   

Abstract

Griseofulvin is not considered effective in treatment of superficial fungal infections. However, when applied topically in organic solvents, the drug appeared in very high concentration in all levels of stratum corneum, and it generally persisted there in measurable amounts for four or more days after a single application. Based on this observation, double-blind experimental prophylactic and therapeutic studies were conducted. Topically applied griseofulvin in alcohol solution was highly effective in preventing experimentally induced Trichophyton mentagraphytes infection, but it had no therapeutic effect once the infection was initiated. Topically administered griseofulvin may prove useful in prevention of recurrences or as an adjunct to therapy in selected cases of superficial fungal infection.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1103743

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  The bioavailability of dermatological and other topically administered drugs.

Authors:  R H Guy; A H Guy; H I Maibach; V P Shah
Journal:  Pharm Res       Date:  1986-10       Impact factor: 4.200

Review 2.  An overview of topical antifungal therapy in dermatomycoses. A North American perspective.

Authors:  A K Gupta; T R Einarson; R C Summerbell; N H Shear
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

3.  Percutaneous absorption of griseofulvin and proquazone in the rat and in isolated human skin.

Authors:  J M Franz; A Gaillard; H I Maibach; A Schweitzer
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

4.  Topical treatment of experimental ringworm in guinea pigs with griseofulvin in dimethylsulfoxide.

Authors:  K Post; J R Saunders
Journal:  Can Vet J       Date:  1979-02       Impact factor: 1.008

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.